Pre-launch · We're opening Reserve Meds to a limited first cohort. Join the waitlist ›
Home / Drugs / Dawnzera

Dawnzera, donidalorsen

Named-patient access overview. Dawnzera is coordinated by Reserve Meds for international patients via physician-led cross-border sourcing.

About Dawnzera

Dawnzera (donidalorsen) is manufactured by Ionis Pharmaceuticals and indicated for HAE prophylaxis, adult/ped >=12 yrs. It is a monoclonal antibody approved by the US FDA in 2025 and may be accessible to international patients through Named Patient Program or personal-import pathways.

How Reserve Meds coordinates Dawnzera

  1. Patient or treating physician submits a named-patient request.
  2. Clinical team verifies appropriateness of Dawnzera for the patient and destination country.
  3. Treating physician issues prescription and clinical justification.
  4. Country-specific NPP / personal-import documentation is prepared.
  5. Dawnzera is sourced from a DSCSA-compliant US specialty wholesaler with full serial traceability.
  6. Shipment is coordinated to the patient's physician or hospital pharmacy (cold-chain where required).

Access by country

Reserve Meds publishes a detailed country deep-dive for Dawnzera in every market we coordinate. Each page below covers the destination-country regulatory pathway (named-patient framework), real costs in local currency and USD, indicative timelines, physician-credential requirements, and cold-chain handling for the route into that country. Tap any country to read the full deep-dive.

Dawnzera in BahrainFull deep-dive on regulatory pathway, costs, timing Dawnzera in EgyptFull deep-dive on regulatory pathway, costs, timing Dawnzera in IndiaFull deep-dive on regulatory pathway, costs, timing Dawnzera in JordanFull deep-dive on regulatory pathway, costs, timing Dawnzera in LebanonFull deep-dive on regulatory pathway, costs, timing Dawnzera in NepalFull deep-dive on regulatory pathway, costs, timing Dawnzera in PakistanFull deep-dive on regulatory pathway, costs, timing Dawnzera in QatarFull deep-dive on regulatory pathway, costs, timing Dawnzera in Saudi ArabiaFull deep-dive on regulatory pathway, costs, timing

Start a request for Dawnzera

Submit a 60-second intake. Our clinical team will reach out as our first cohort opens with case-specific feasibility, timeline, and a formal quote.

Join the Dawnzera waitlist

About Dawnzera

Rare Disease (HAE prophylaxis)
Manufacturer: Ionis Pharmaceuticals
Generic: donidalorsen

Why Reserve Meds

DSCSA-compliant US sourcing. Physician-led. On-pathway in every destination. Patient-first intake with a named concierge.

Related

Access pathways
Country guidance
Articles & guides